Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Agilon Health ( (AGL) ) has issued an announcement.
On November 5, 2025, agilon health received a notice from the New York Stock Exchange indicating non-compliance with listing standards due to its stock price falling below $1.00 per share over a 30-day period. The company plans to address this by pursuing a reverse stock split, pending stockholder approval at its 2026 annual meeting, to regain compliance and maintain its NYSE listing.
The most recent analyst rating on (AGL) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Agilon Health stock, see the AGL Stock Forecast page.
Spark’s Take on AGL Stock
According to Spark, TipRanks’ AI Analyst, AGL is a Neutral.
Agilon Health’s overall stock score reflects significant financial and technical challenges. The company’s declining revenues, negative profitability metrics, and bearish technical indicators weigh heavily on its score. While there are some positive strategic initiatives and operational improvements noted in the earnings call, these are not sufficient to offset the current financial and valuation concerns.
To see Spark’s full report on AGL stock, click here.
More about Agilon Health
agilon health is a company that partners with physicians to transform healthcare in communities by transitioning to a value-based Total Care Model for senior patients. The company provides technology, capital, and access to a network of primary care physicians, enabling physician partners to focus on the total health of their patients.
Average Trading Volume: 8,704,481
Technical Sentiment Signal: Sell
Current Market Cap: $312.4M
Find detailed analytics on AGL stock on TipRanks’ Stock Analysis page.